Bereich
Rheumatologie
RHEUMA · Dept. I
The advent of biosimilars: challenges and risks
Müller R, Renner C, Gabay C, Cassata G, Lohri A, Hasler P. The advent of biosimilars: challenges and risks. Swiss Med Wkly 2014; 144:w13980.
01.07.2014The advent of biosimilars: challenges and risks
01.07.2014Swiss Med Wkly 2014; 144:w13980
Müller Rüdiger, Renner Christoph, Gabay Cem, Cassata Giuseppe, Lohri Andreas, Hasler Paul
Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase
Schiff M, von Kempis J, Goldblum R, Tesser J, Müller R. Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase. Ann Rheum Dis 2014; 73:2174-7.
27.06.2014Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase
27.06.2014Ann Rheum Dis 2014; 73:2174-7
Schiff Michael H, von Kempis Johannes, Goldblum Ronald, Tesser John R, Müller Rüdiger
Biological agents in monotherapy for the treatment of rheumatoid arthritis
Gabay C, Hasler P, Kyburz D, So A, Villiger P, von Kempis J, Walker U. Biological agents in monotherapy for the treatment of rheumatoid arthritis. Swiss Med Wkly 2014; 144:w13950.
10.04.2014Biological agents in monotherapy for the treatment of rheumatoid arthritis
10.04.2014Swiss Med Wkly 2014; 144:w13950
Gabay C, Hasler P, Kyburz D, So A, Villiger P, von Kempis Johannes, Walker U
Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort
Müller R, Kaegi T, Finckh A, Haile S, Schulze-Koops H, von Kempis J, on behalf of the SCQM physicians. Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort. Rheumatology (Oxford) 2013
17.12.2013Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort
17.12.2013Rheumatology (Oxford) 2013
Müller Rüdiger, Kaegi Toni, Finckh Axel, Haile Sarah, Schulze-Koops Hendrik, von Kempis Johannes, on behalf of the SCQM physicians
Tumor necrosis factor-alpha inhibition in radiographic and non-radiographic axial spondyloarthritis: results from a large observational cohort
Müller R. Tumor necrosis factor-alpha inhibition in radiographic and non-radiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum 2013; 2013:3096-3106.
14.12.2013Tumor necrosis factor-alpha inhibition in radiographic and non-radiographic axial spondyloarthritis: results from a large observational cohort
14.12.2013Arthritis Rheum 2013; 2013:3096-3106
Müller Rüdiger
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort
Ciurea A, Weber U, Boonen A, Dougados M, van der Heijde D, Michel B, Nissen M, Müller R, Weiss B, Tamborrini G, Rufibach K, Stekhoven D, Kissling R, Beyeler B, Dudler J, Bernhard J, Exer P, Scherer A, Rheumatologists of the Swiss Clinical Quality Management Program for Axial Spondyloarthritis. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum 2013; 65:3096-106.
01.12.2013Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort
01.12.2013Arthritis Rheum 2013; 65:3096-106
Ciurea Adrian, Weber Ulrich, Boonen Annelies, Dougados Maxime, van der Heijde Désirée, Michel Beat A, Nissen Michael J, Müller Rüdiger, Weiss Bettina, Tamborrini Giorgio, Rufibach Kaspar, Stekhoven Daniel, Kissling Rudolf, Beyeler Brigitte, Dudler Jean, Bernhard Jürg, Exer Pascale, Scherer Almut, Rheumatologists of the Swiss Clinical Quality Management Program for Axial Spondyloarthritis
Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination
Müller R, Maier R, Hoschler K, Zambon M, Ludewig B, Herrmann M, Schulze-Koops H, von Kempis J. Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination. Clin Exp Rheumatol 2013; 31:723-30.
14.06.2013Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination
14.06.2013Clin Exp Rheumatol 2013; 31:723-30
Müller Rüdiger, Maier Reinhard, Hoschler Katja, Zambon Maria, Ludewig Burkhard, Herrmann Martin, Schulze-Koops Hendrik, von Kempis Johannes
Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective
Zeidler J, Mittendorf T, Müller R, von Kempis J. Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective. Health Econ Rev 2012; 2:20.
28.09.2012Biologic TNF inhibiting agents for treatment of inflammatory rheumatic diseases: dosing patterns and related costs in Switzerland from a payers perspective
28.09.2012Health Econ Rev 2012; 2:20
Zeidler Jan, Mittendorf Thomas, Müller Rüdiger, von Kempis Johannes
Detection of low level cryoglobulins by flow cytometry
Müller R, Schett G, von Kempis J, Sheriff A, Maihöfner C, Kern P, Franz S, Munoz L, Winkler S, Vogt B, Herrmann M. Detection of low level cryoglobulins by flow cytometry. Cytometry A 2012; 81:883-7.
07.09.2012Detection of low level cryoglobulins by flow cytometry
07.09.2012Cytometry A 2012; 81:883-7
Müller Rüdiger, Schett Georg, von Kempis Johannes, Sheriff Ahmed, Maihöfner Christian, Kern Peter, Franz Sandra, Munoz Luis E, Winkler Silke, Vogt Birgit, Herrmann Martin
Use of abatacept in rheumatoid arthritis
von Kempis J, Dudler J, Hasler P, Kyburz D, Tyndall A, Zufferey P, Villiger P. Use of abatacept in rheumatoid arthritis. Swiss Med Wkly 2012; 142:w13581.
11.05.2012Use of abatacept in rheumatoid arthritis
11.05.2012Swiss Med Wkly 2012; 142:w13581
von Kempis Johannes, Dudler Jean, Hasler Paul, Kyburz Diego, Tyndall Alan, Zufferey Pascal, Villiger Peter M
Clinical Trials in Rheumatology
Müller R. Clinical Trials in Rheumatology - 2. Auflage. Heidelberg: Springer, 2011. ISBN 978-1-4471-2869-4.
01.01.2012Clinical Trials in Rheumatology
01.01.2012Springer, ISBN 978-1-4471-2869-4
Müller Rüdiger
Scoring adult-onset Still's disease
Müller R, Sheriff A. Scoring adult-onset Still's disease. J Rheumatol 2010; 37:2203-4.
01.11.2010Scoring adult-onset Still's disease
01.11.2010J Rheumatol 2010; 37:2203-4
Müller Rüdiger, Sheriff Ahmed
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion
Walker U, Courvoisier D, Dudler J, Aeberli D, von Kempis J, Scherer A, Finckh A, Swiss Clinical Quality Management Programme in Rheumatic Diseases. Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion. Rheumatology (Oxford) 2010; 50:243-4.
17.08.2010Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion
17.08.2010Rheumatology (Oxford) 2010; 50:243-4
Walker Ulrich A, Courvoisier Delphine S, Dudler Jean, Aeberli Daniel, von Kempis Johannes, Scherer Almut, Finckh Axel, Swiss Clinical Quality Management Programme in Rheumatic Diseases
Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus
Weber C, Voll R, Schett G, Burkhardt H, Müller R, Distler J, Graef D, Mielenz D, Sehnert B, Englbrecht M, Haslbeck M, Fürnrohr B. Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus. Rheumatology (Oxford) 2010; 49:2255-63.
17.08.2010Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus
17.08.2010Rheumatology (Oxford) 2010; 49:2255-63
Weber Christian K, Voll Reinhard E, Schett Georg, Burkhardt Harald, Müller Rüdiger, Distler Jörg H, Graef Daniela, Mielenz Dirk, Sehnert Bettina, Englbrecht Matthias, Haslbeck Martin, Fürnrohr Barbara G
Clinical Trials in Rheumatology
Müller R, von Kempis J. Clinical Trials in Rheumatology. Heidelberg: Springer, 2009. ISBN 978-1-84996-383-1.
01.01.2010Clinical Trials in Rheumatology
01.01.2010Springer, ISBN 978-1-84996-383-1
Müller Rüdiger, von Kempis Johannes
Rheuma-Drugfinder 2010
Müller R, von Kempis J. Rheuma-Drugfinder 2010. 2010
01.01.2010Rheuma-Drugfinder 2010
01.01.20102010
Müller Rüdiger, von Kempis Johannes
Abdominal pain in a patient with ankylosing spondylitis under treatment with infliximab
Cooper J, Flückiger B, Traichl B, Diener P, Otto P, von Kempis J. Abdominal pain in a patient with ankylosing spondylitis under treatment with infliximab. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2009; 15:244-6.
01.08.2009Abdominal pain in a patient with ankylosing spondylitis under treatment with infliximab
01.08.2009Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2009; 15:244-6
Cooper Julian, Flückiger Beat, Traichl Birgit, Diener Pierre-André, Otto Petra, von Kempis Johannes
Increased expression of CD154 and FAS in SLE patients' lymphocytes
Manea M, Müller R, Dejica D, Sheriff A, Schett G, Herrmann M, Kern P. Increased expression of CD154 and FAS in SLE patients' lymphocytes. Rheumatology international 2009; 30:181-185.
30.04.2009Increased expression of CD154 and FAS in SLE patients' lymphocytes
30.04.2009Rheumatology international 2009; 30:181-185
Manea Maria Elena, Müller Rüdiger, Dejica Doru, Sheriff Ahmed, Schett Georg, Herrmann Martin, Kern Peter
Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-alpha-elicited endothelial activation
Di Comite G, Corti A, Sabbadini M, Rovere-Querini P, Voll R, Herrmann M, Müller R, Aiello P, Baldissera E, Lolmede K, Marinosci A, Rossi C, Manfredi A. Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-alpha-elicited endothelial activation. Journal of leukocyte biology 2009; 85:81-7.
01.01.2009Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-alpha-elicited endothelial activation
01.01.2009Journal of leukocyte biology 2009; 85:81-7
Di Comite Gabriele, Corti Angelo, Sabbadini Maria Grazia, Rovere-Querini Patrizia, Voll Reinhard E, Herrmann Martin, Müller Rüdiger, Aiello Patrizia, Baldissera Elena, Lolmede Karine, Marinosci Alessandro, Rossi Carlo M, Manfredi Angelo A
Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis
Herman S, Müller-Ladner U, Neumann E, Gelse H, Hueber A, Redlich K, Zwerina J, Krönke G, Müller R, Schett G. Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis. Arthritis and rheumatism 2008; 58:3041-50.
01.10.2008Induction of osteoclast-associated receptor, a key osteoclast costimulation molecule, in rheumatoid arthritis
01.10.2008Arthritis and rheumatism 2008; 58:3041-50
Herman Sonja, Müller-Ladner Ulf, Neumann Elena, Gelse Holger, Hueber Axel J, Redlich Kurt, Zwerina Jochen, Krönke Gerhard, Müller Rüdiger, Schett Georg